Home / ACCCBuzz Blog / Full Story

ACCC Urges Congress to Revise Drug Pricing Legislation


February 1, 2022
Advocacy Letters

ACCC wrote a letter to Senate Finance Committee Chairman Ron Wyden and Ranking Member Mike Crapo regarding drug pricing legislation being worked on by members of Congress. The letter asks that Congress remove providers from the middle of proposed drug pricing negotiations between the federal government and drug manufactures, siting the potential for negative repercussions on cancer care providers and their patients. 
Read Letter


«« Previous
ACCC Encourages Congress to Fund Cancer Moonshot Initiatives
Next »»
ACCC Co-signs Letter to Establish Pathway for Telehealth Reform

Categories

We welcome you to share our blog content. We want to connect people with the information they need. We just ask that you link back to the original post and refrain from editing the text. Any questions? Email Rachel Radwan, Content & Strategy Coordinator.

To receive a weekly digest of ACCCBuzz blog posts each Friday, please sign up in the box to the left.

 

More Blog Posts

Related Content